OMEGA THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.41 USD | +1.26% |
|
+22.96% | -19.93% |
| 06/05 | Omega Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 16/04 | Omega Therapeutics CFO Joshua Reed to Depart | MT |
Presenter SpeechMitchell Kapoor (Analysts)Good morning, ladies and gentlemen. My name is Mitch...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Omega Therapeutics, Inc. is a clinical-stage biotechnology company, which is engaged in the development of a programmable epigenomic mRNA medicine to treat or cure a broad range of diseases. The Companyâs OMEGA platform has enabled it to identify and validate various DNA-sequence-based epigenomic, zip codes, associated with individual regulatory elements within Insulated Genomic Domains (IGDs). The Company designs and engineers its mRNA therapeutics, called epigenomic controllers, or ECs, to target EpiZips for precision epigenomic control. Its pipeline consists of programs that span oncology, regenerative medicine, and multigenic diseases including immunologic and cardiometabolic conditions. The Companyâs precision epigenomic control delivered by the OMEGA platform has therapeutic applicability and transformational potential, spanning across oncology, multigenic diseases including immunologic and cardiometabolic conditions, and regenerative medicine.
Calendar
21/06/2024
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
2.41
USD
Average target price
11
USD
Spread / Average Target
+356.43%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -19.93% | 133M | |
| -0.09% | 42.12B | |
| +49.62% | 42.05B | |
| -4.96% | 29.18B | |
| +11.18% | 26.02B | |
| -21.95% | 18.9B | |
| +8.61% | 13.21B | |
| +24.73% | 12.17B | |
| +28.31% | 12.16B | |
| -6.26% | 11.42B |
- Stock Market
- Equities
- OMGA Stock
- News Omega Therapeutics, Inc.
- Transcript : Omega Therapeutics, Inc. Presents at H.C. Wainwright 24th Annual Global Investment Conference, Sep-12-2022 10
